Bortezomib | High-Quality Pharmaceutical Reference Standard
Bortezomib API is a proteasome inhibitor used in the treatment of multiple myeloma and mantle cell lymphoma. It induces cancer cell apoptosis by disrupting protein degradation pathways and is manufactured under GMP standards for injectable formulations.
Bortezomib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 6
